MOLN
Molecular Partners AG
Price Chart
Latest Quote
$3.86
+0.05 (+1.31%)
Current Price
| Previous Close | $3.81 |
| Open | $3.90 |
| Day High | $3.90 |
| Day Low | $3.73 |
| Volume | 13,059 |
Stock Information
Note: Financial values converted from CHF to USD
| Shares Outstanding | 37.51M |
| Total Debt | $4.12M |
| Cash Equivalents | $96.97M |
| Net Income | $-71.44M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $144.79M |
| EPS (TTM) | $-1.92 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $67.49M |
| Income | $-71.44M |
| Book/sh | $2.26 |
| Cash/sh | $2.10 |
| Employees | 134 |
Financial Ratios
| Quick Ratio | 9.21 |
| Current Ratio | 9.43 |
| Debt/Eq | 4.88 |
Returns & Margins
| ROA | -28.82% |
| ROE | -59.01% |
Ownership
| Institutional Ownership | 9.58% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -14.45 |
| P/B | 1.71 |
Analyst Data
| Recommendation | none |
| Target Price | $10.75 |
Technical Indicators
| SMA20 | $3.93 |
| SMA50 | $4.06 |
| SMA200 | $4.17 |
| RSI | 45.30 |
| ATR | 0.2099 |
| Shares Float | 19.92M |
| Short Float | 0.05% |
| Short Ratio | 1.76 |
| Volatility | 0.71 |
| Rel Volume | 1.94 |
Performance History
| Week | -1.53% |
| Month | -7.66% |
| Quarter | -11.26% |
| 6 Months | -12.07% |
| YTD | -8.53% |
| Year | +7.82% |
| 3 Years | -43.09% |
| 5 Years | -80.36% |
| 10 Years | -80.36% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $3.86 | 13,059 |
| 2026-06-23 | $3.81 | 27,300 |
| 2026-06-22 | $3.95 | 7,600 |
| 2026-06-18 | $3.82 | 1,000 |
| 2026-06-17 | $3.90 | 5,000 |
| 2026-06-16 | $3.92 | 24,500 |
| 2026-06-15 | $3.85 | 5,700 |
| 2026-06-12 | $4.11 | 1,800 |
| 2026-06-11 | $3.71 | 800 |
| 2026-06-10 | $3.72 | 4,500 |
| 2026-06-09 | $3.88 | 2,300 |
| 2026-06-08 | $3.95 | 6,200 |
| 2026-06-05 | $4.10 | 2,100 |
| 2026-06-04 | $3.93 | 2,300 |
| 2026-06-03 | $4.03 | 14,600 |
| 2026-06-02 | $3.92 | 6,300 |
| 2026-06-01 | $3.95 | 1,000 |
| 2026-05-29 | $4.20 | 1,200 |
| 2026-05-28 | $4.00 | 3,900 |
| 2026-05-27 | $4.04 | 3,700 |
| 2026-05-26 | $4.05 | 4,600 |
About Molecular Partners AG
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in Phase 1 clinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and MP0726, a Radio-DARPin Therapy to treat ovarian cancer and other MSLNexpressing cancers. In addition, the company develops MP0621, a Switch-DARPin candidate targeting CD16a, c-KIT, and CD47 as conditioning for hematopoietic stem cell transplantation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates and Eckert & Ziegler SE to develop Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
đ° Latest News
Eckert & Ziegler SE (XTER:EUZ) Q1 2026 Earnings Call Highlights: Strong Medical Division ...
GuruFocus.com âĸ 2026-05-14T01:03:33Z3 European Penny Stocks With Market Caps Under âŦ600M
Simply Wall St. âĸ 2026-04-06T11:05:11Z
Molecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready
MarketBeat âĸ 2026-02-02T20:30:57Z
Molecular Partners AG (VTX:MOLN) is definitely on the radar of hedge funds investors who own 50% of the company
Simply Wall St. âĸ 2025-09-30T05:47:10Z
Stocks Look Set to Open Trading Session Marginally Lower Wednesday as Investors Look Ahead to Nvidia Earnings
MT Newswires âĸ 2025-08-27T13:26:44Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $6,255,034 | $8,857,733 | $238,567,258 |
| Operating Revenue | $0 | $6,255,034 | $8,857,733 | $238,567,258 |
| Expenses | ||||
| Interest Expense | $22,654 | $31,464 | $42,791 | $761,428 |
| Total Expenses | $69,769,432 | $83,300,192 | $85,765,707 | $91,803,011 |
| Other Income Expense | $-9,693,415 | $4,820,278 | $-6,426,198 | $902,386 |
| Net Non Operating Interest Income Expense | $1,873,993 | $4,211,136 | $5,323,701 | $658,226 |
| Total Other Finance Cost | $18,878 | $16,361 | $18,878 | $17,620 |
| Interest Expense Non Operating | $22,654 | $31,464 | $42,791 | $761,428 |
| Operating Expense | $69,769,432 | $83,300,192 | $85,765,707 | $91,803,011 |
| General And Administrative Expense | $18,716,019 | $21,601,893 | $23,906,313 | $27,464,257 |
| Other Operating Expenses | - | - | - | $-55,377 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-77,591,372 | $-68,016,261 | $-78,010,471 | $148,324,860 |
| Net Interest Income | $1,873,993 | $4,211,136 | $5,323,701 | $658,226 |
| Interest Income | $1,915,526 | $4,258,961 | $5,385,371 | $1,437,273 |
| Normalized Income | $-68,721,897 | $-72,426,815 | $-72,824,530 | $147,597,536 |
| Net Income From Continuing And Discontinued Operation | $-77,591,372 | $-68,016,261 | $-78,010,471 | $148,324,860 |
| Total Operating Income As Reported | $-73,152,437 | $-77,045,157 | $-76,907,974 | $146,764,247 |
| Net Income Common Stockholders | $-77,591,372 | $-68,016,261 | $-78,010,471 | $148,324,860 |
| Net Income | $-77,591,372 | $-68,016,261 | $-78,010,471 | $148,324,860 |
| Net Income Including Noncontrolling Interests | $-77,591,372 | $-68,016,261 | $-78,010,471 | $148,324,860 |
| Net Income Continuous Operations | $-77,591,372 | $-68,016,261 | $-78,010,471 | $148,324,860 |
| Pretax Income | $-77,588,854 | $-68,013,744 | $-78,010,471 | $148,324,860 |
| Special Income Charges | $-3,384,263 | $0 | $0 | - |
| Interest Income Non Operating | $1,915,526 | $4,258,961 | $5,385,371 | $1,437,273 |
| Operating Income | $-69,769,432 | $-77,045,157 | $-76,907,974 | $146,764,247 |
| Depreciation Amortization Depletion Income Statement | $466,925 | $527,336 | $461,891 | $523,560 |
| Depreciation And Amortization In Income Statement | $466,925 | $527,336 | $461,891 | $523,560 |
| Per Share | ||||
| Diluted EPS | $-2.08 | $-2.00 | $-2.38 | $4.46 |
| Basic EPS | $-2.08 | $-2.00 | $-2.38 | $4.57 |
| Other | ||||
| Tax Effect Of Unusual Items | $-823,940 | $409,724 | $-1,240,256 | $175,063 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-65,174,436 | $-69,821,033 | $-68,495,771 | $151,189,338 |
| Total Unusual Items | $-9,693,415 | $4,820,278 | $-6,426,198 | $902,386 |
| Total Unusual Items Excluding Goodwill | $-9,693,415 | $4,820,278 | $-6,426,198 | $902,386 |
| Reconciled Depreciation | $2,698,349 | $2,981,524 | $3,045,711 | $3,005,437 |
| EBITDA (Bullshit earnings) | $-74,867,852 | $-65,000,755 | $-74,921,970 | $152,091,724 |
| EBIT | $-77,566,200 | $-67,982,280 | $-77,967,680 | $149,086,287 |
| Diluted Average Shares | $46,908,076 | $42,831,937 | $41,243,789 | $41,866,652 |
| Basic Average Shares | $46,908,076 | $42,831,937 | $41,243,789 | $40,865,331 |
| Diluted NI Availto Com Stockholders | $-77,591,372 | $-68,016,261 | $-78,010,471 | $148,324,860 |
| Tax Provision | $2,517 | $2,517 | $0 | $0 |
| Restructuring And Mergern Acquisition | $3,384,263 | $0 | $0 | - |
| Gain On Sale Of Security | $-6,309,152 | $4,820,278 | $-6,426,198 | $902,386 |
| Research And Development | $50,586,488 | $61,170,963 | $61,397,503 | $63,870,570 |
| Selling General And Administration | $18,716,019 | $21,601,893 | $23,906,313 | $27,464,257 |
| Other Gand A | $6,398,510 | $7,806,837 | $9,256,696 | $12,628,373 |
| Salaries And Wages | $12,317,509 | $13,795,056 | $14,649,617 | $14,835,884 |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $101,102,497 | $178,196,738 | $221,779,350 | $295,629,028 |
| Total Assets | $128,507,602 | $199,516,714 | $249,637,536 | $330,066,956 |
| Total Non Current Assets | $6,583,518 | $5,345,097 | $7,416,683 | $9,446,738 |
| Goodwill And Other Intangible Assets | $2,517 | $61,669 | $266,814 | $341,069 |
| Other Intangible Assets | $2,517 | $61,669 | $266,814 | $341,069 |
| Current Assets | $121,924,084 | $194,171,618 | $242,220,853 | $320,620,219 |
| Other Current Assets | $-1,259 | - | - | - |
| Prepaid Assets | $2,408,880 | $2,830,497 | $3,128,776 | $4,920,963 |
| Receivables | $2,397,553 | $3,263,441 | $3,881,393 | $2,137,032 |
| Other Receivables | $191,301 | $444,271 | $1,506,494 | $948,953 |
| Taxes Receivable | $1,887,837 | $2,459,223 | $2,003,625 | $532,370 |
| Accounts Receivable | $318,415 | $359,948 | $371,275 | $655,709 |
| Cash Cash Equivalents And Short Term Investments | $117,118,909 | $188,077,679 | $235,210,683 | $313,562,224 |
| Cash And Cash Equivalents | $104,023,611 | $80,389,146 | $84,712,294 | $110,685,159 |
| Cash Financial | $104,023,611 | $80,389,146 | $84,712,294 | $110,685,159 |
| Other Non Current Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $4,586,186 | $3,075,916 | $4,596,255 | $6,104,007 |
| Long Term Debt And Capital Lease Obligation | $3,068,365 | $1,544,251 | $3,075,916 | $4,596,255 |
| Current Debt And Capital Lease Obligation | $1,517,821 | $1,531,665 | $1,520,338 | $1,507,753 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $27,402,588 | $21,258,307 | $27,591,371 | $34,096,859 |
| Total Non Current Liabilities Net Minority Interest | $13,524,466 | $7,684,756 | $9,447,996 | $12,385,471 |
| Other Non Current Liabilities | $1,259 | - | - | - |
| Tradeand Other Payables Non Current | $201,369 | $0 | - | - |
| Current Liabilities | $13,878,121 | $13,573,550 | $18,143,375 | $21,711,388 |
| Other Current Liabilities | $1,259 | - | - | - |
| Payables And Accrued Expenses | $12,359,042 | $12,041,885 | $11,169,704 | $12,137,535 |
| Payables | $2,222,614 | $2,339,660 | $1,671,365 | $2,697,090 |
| Other Payable | $1,043,345 | $1,485,099 | $1,155,356 | $1,442,308 |
| Accounts Payable | $1,179,269 | $854,561 | $516,009 | $1,254,783 |
| Current Deferred Liabilities | - | $0 | $5,453,333 | $8,066,100 |
| Non Current Deferred Liabilities | - | - | $0 | $4,577,376 |
| Total Tax Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $101,105,014 | $178,258,408 | $222,046,165 | $295,970,098 |
| Total Equity Gross Minority Interest | $101,105,014 | $178,258,408 | $222,046,165 | $295,970,098 |
| Stockholders Equity | $101,105,014 | $178,258,408 | $222,046,165 | $295,970,098 |
| Retained Earnings | $-392,359,295 | $-309,974,075 | $-241,334,828 | $-160,818,567 |
| Gains Losses Not Affecting Retained Earnings | - | - | - | $-1,234,646 |
| Other Equity Adjustments | - | - | - | $-1,234,646 |
| Other | ||||
| Treasury Shares Number | $3,729,074 | $4,404,954 | $4,404,954 | - |
| Ordinary Shares Number | $47,084,762 | $46,394,350 | $41,349,045 | $45,364,360 |
| Share Issued | $50,813,836 | $50,799,304 | $45,753,999 | $45,364,360 |
| Tangible Book Value | $101,102,497 | $178,196,738 | $221,779,350 | $295,629,028 |
| Invested Capital | $101,105,014 | $178,258,408 | $222,046,165 | $295,970,098 |
| Working Capital | $108,045,963 | $180,598,067 | $224,077,478 | $298,908,831 |
| Capital Lease Obligations | $4,586,186 | $3,075,916 | $4,596,255 | $6,104,007 |
| Total Capitalization | $101,105,014 | $178,258,408 | $222,046,165 | $295,970,098 |
| Treasury Stock | $1,420,912 | $1,234,646 | $1,234,646 | $1,234,646 |
| Additional Paid In Capital | $489,804,422 | $484,387,587 | $460,040,779 | $453,487,466 |
| Capital Stock | $5,080,799 | $5,079,541 | $4,574,859 | $4,535,844 |
| Common Stock | $5,080,799 | $5,079,541 | $4,574,859 | $4,535,844 |
| Employee Benefits | $10,253,474 | $6,140,505 | $6,372,080 | $3,211,841 |
| Long Term Capital Lease Obligation | $3,068,365 | $1,544,251 | $3,075,916 | $4,596,255 |
| Current Capital Lease Obligation | $1,517,821 | $1,531,665 | $1,520,338 | $1,507,753 |
| Current Accrued Expenses | $10,136,428 | $9,702,225 | $9,498,339 | $9,440,445 |
| Net PPE | $6,581,001 | $5,283,427 | $7,149,869 | $9,105,669 |
| Accumulated Depreciation | $-25,012,586 | $-22,987,566 | $-20,567,358 | $-18,497,030 |
| Gross PPE | $31,593,586 | $28,270,993 | $27,717,227 | $27,602,698 |
| Leases | $796,667 | $796,667 | $796,667 | $785,340 |
| Other Properties | $28,483,689 | $24,690,395 | $24,360,653 | $12,140,052 |
| Machinery Furniture Equipment | $2,313,230 | $2,783,931 | $2,559,907 | $14,677,306 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $13,095,298 | $107,688,532 | $150,498,390 | $202,877,065 |
| Current Deferred Revenue | - | $0 | $5,453,333 | $8,066,100 |
| Non Current Deferred Revenue | - | - | $0 | $4,577,376 |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-65,411,823 | $-75,480,796 | $-75,281,934 | $147,446,262 |
| Operating Activities | ||||
| Operating Cash Flow | $-64,513,167 | $-74,570,813 | $-74,264,968 | $149,229,729 |
| Cash Flow From Continuing Operating Activities | $-64,510,650 | $-74,570,813 | $-74,264,968 | $149,229,729 |
| Operating Gains Losses | $-687,207 | $-843,276 | $673,363 | $1,443,639 |
| Investing Activities | ||||
| Capital Expenditure | $-898,656 | $-909,983 | $-1,016,966 | $-1,783,467 |
| Investing Cash Flow | $91,311,738 | $50,956,554 | $56,181,092 | $-127,273,075 |
| Cash Flow From Continuing Investing Activities | $91,311,738 | $50,956,554 | $56,181,092 | $-127,273,075 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $21,827,016 | $0 | $0 |
| Financing Cash Flow | $-1,446,156 | $18,165,686 | $-1,468,811 | $-1,976,036 |
| Cash Flow From Continuing Financing Activities | $-1,446,156 | $18,165,686 | $-1,468,811 | $-1,976,036 |
| Net Common Stock Issuance | $0 | $21,827,016 | $0 | $-794,190 |
| Common Stock Issuance | $0 | $21,827,016 | $0 | $0 |
| Repurchase Of Capital Stock | - | $0 | $0 | $-794,190 |
| Net Other Financing Charges | - | $-2,191,260 | - | - |
| Other | ||||
| Repayment Of Debt | $-1,525,449 | $-1,520,415 | $-1,507,829 | $-1,496,501 |
| End Cash Position | $104,028,851 | $80,393,196 | $84,716,561 | $110,690,735 |
| Beginning Cash Position | $80,393,196 | $84,716,561 | $110,690,735 | $90,385,393 |
| Effect Of Exchange Rate Changes | $-1,716,760 | $1,125,208 | $-6,421,487 | $324,724 |
| Changes In Cash | $25,352,415 | $-5,448,573 | $-19,552,687 | $19,980,618 |
| Proceeds From Stock Option Exercised | $79,293 | $50,345 | $39,017 | $314,655 |
| Net Issuance Payments Of Debt | $-1,525,449 | $-1,520,415 | $-1,507,829 | $-1,496,501 |
| Net Long Term Debt Issuance | $-1,525,449 | $-1,520,415 | $-1,507,829 | $-1,496,501 |
| Long Term Debt Payments | $-1,525,449 | $-1,520,415 | $-1,507,829 | $-1,496,501 |
| Interest Received Cfi | $2,173,640 | $5,335,297 | $4,816,745 | $621,759 |
| Net Investment Purchase And Sale | $90,036,755 | $46,531,241 | $52,381,314 | $-126,111,367 |
| Sale Of Investment | $173,455,677 | $348,657,063 | $402,057,860 | $250,741,337 |
| Purchase Of Investment | $-83,418,922 | $-302,125,822 | $-349,676,546 | $-376,852,704 |
| Net Intangibles Purchase And Sale | $0 | $-22,655 | $-293,259 | $-302,069 |
| Purchase Of Intangibles | $0 | $-22,655 | $-293,259 | $-302,069 |
| Net PPE Purchase And Sale | $-898,656 | $-887,328 | $-723,707 | $-1,481,398 |
| Purchase Of PPE | $-898,656 | $-887,328 | $-723,707 | $-1,481,398 |
| Interest Paid Cfo | $-22,655 | $-32,724 | $-42,793 | $-813,070 |
| Change In Working Capital | $1,522,932 | $-4,778,986 | $-7,564,316 | $-7,564,316 |
| Change In Other Working Capital | $-22,655 | $-5,502,694 | $-7,216,936 | $-31,828,023 |
| Change In Other Current Assets | $421,638 | $298,293 | $1,792,277 | $2,249,157 |
| Change In Payables And Accrued Expense | $513,518 | $862,156 | $-965,363 | $-9,783,266 |
| Change In Accrued Expense | $431,707 | $202,638 | $56,638 | $-3,063,485 |
| Change In Payable | $81,810 | $659,518 | $-1,022,001 | $-6,719,781 |
| Change In Receivables | $610,431 | $-436,742 | $-1,174,294 | $31,797,816 |
| Other Non Cash Items | $4,006,193 | $-9,046,972 | $1,083,673 | $-1,578,311 |
| Stock Based Compensation | $5,561,849 | $5,166,642 | $6,553,643 | $6,403,867 |
| Deferred Tax | $2,517 | $2,517 | $0 | $0 |
| Deferred Income Tax | $2,517 | $2,517 | $0 | $0 |
| Depreciation Amortization Depletion | $2,698,485 | $2,981,675 | $3,045,864 | $3,005,588 |
| Depreciation And Amortization | $2,698,485 | $2,981,675 | $3,045,864 | $3,005,588 |
| Amortization Cash Flow | $57,897 | $227,811 | $367,518 | - |
| Amortization Of Intangibles | $57,897 | $227,811 | $367,518 | - |
| Depreciation | $2,639,329 | $2,753,864 | $2,678,347 | - |
| Pension And Employee Benefit Expense | $-687,207 | $-843,276 | $673,363 | $1,443,639 |
| Net Income From Continuing Operations | $-77,595,280 | $-68,019,687 | $-78,014,401 | $148,332,331 |
| Common Stock Payments | - | $0 | $0 | $-794,190 |
| Taxes Refund Paid | - | $0 | $0 | $0 |
| Change In Account Payable | - | $659,518 | $-1,022,001 | $-6,719,781 |
| Change In Prepaid Assets | - | - | - | - |
Fetched: 2026-06-16